Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 21, 2020

Astellas Pharma gets FDA fast track status for ASP036 to treat primary mitochondrial myopathies

Astellas Pharma has secured fast track status from the US Food and Drug Administration (FDA) to develop ASP0367/MA-0211 (ASP0367) as a potential treatment for primary mitochondrial myopathies (PMM).

Continue
The US FDA’s Center for Drug Evaluation and Research. (Credit: The U.S. Food and Drug Administration)
October 21, 2020

JSR Life Sciences to expand KBI Biopharma and Selexis’ biologics manufacturing capabilities

JSR Life Sciences is set to expand KBI Biopharma and Selexis’ biologics manufacturing capabilities in Switzerland. (Credit: Ri Butov from Pixabay)
October 20, 2020

Vifor Pharma, Cara Therapeutics to commercialise kidney disease drug Korsuva in US

Vifor Pharma and Cara Therapeutics have agreed to commercialise kidney disease drug Korsuva in the US. (Credit: Riki Risnandar from Pixabay)

Contracts

September 23, 2020

Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine. (Credit: Pete Linforth from Pixabay)

Sanofi, GSK sign deal to supply 300 million doses of Covid-19 vaccine in EU states

Catalent to expand manufacturing for Covid-19 vaccine candidate AZD1222

Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate

Deals

Deals October 16, 2020

Eli Lilly to buy biotechnology firm Disarm Therapeutics

Pharmaceutical Business Review

HitGen to acquire fragment and structure-based biotech company Vernalis

Bristol Myers Squibb to buy biopharmaceutical firm MyoKardia for $13.1bn

Covis Group to buy AMAG Pharmaceuticals for $498m

Popular

  1. Dr. Reddy’s, RDIF secure DCGI’s approval for Sputnik V vaccine trial in India
  2. ImmunityBio gets FDA authorisation to begin trial of novel Covid-19 vaccine candidate
  3. Regeneron’s Inmazeb gets FDA approval for Ebola treatment
  4. World Bank sanctions $12bn to help countries access Covid-19 vaccines
  5. J&J halts Covid-19 vaccine trials after unexplained illness in participant

PRESS RELEASES

SGS Wins ‘Highly Commended’ Award in the 2020 Vaccine Industry Excellence Awards
SGS Wins ‘Highly Commended’ Award in the 2020 Vaccine Industry Excellence Awards
Pharmaceutical Business Review
Softigel by Procaps Launches New Website
Gerresheimer Producing US Type Containers and Caps in Europe
Gerresheimer Producing US Type Containers and Caps in Europe
Gerresheimer on Track for Strong Second Half-Year
Gerresheimer on Track for Strong Second Half-Year
Gerresheimer Signs Agreement for €325m Promissory Loan
Gerresheimer Signs Agreement for €325m Promissory Loan

Suppliers

Whitepapers

Managing Human Challenge Trials
Managing Human Challenge Trials
Six Steps to Handle High-potent Molecules in a Shared Facility
Six Steps to Handle High-potent Molecules in a Shared Facility
Unique 3D-shaped Spirocycles to Explore Novel Chemical Space
Unique 3D-shaped Spirocycles to Explore Novel Chemical Space